Basel Medical Group Statistics
Total Valuation
BMGL has a market cap or net worth of $11.09 million. The enterprise value is $8.50 million.
Important Dates
The last earnings date was Tuesday, November 4, 2025, before market open.
| Earnings Date | Nov 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BMGL has 18.79 million shares outstanding. The number of shares has increased by 15.61% in one year.
| Current Share Class | 18.79M |
| Shares Outstanding | 18.79M |
| Shares Change (YoY) | +15.61% |
| Shares Change (QoQ) | +31.21% |
| Owned by Insiders (%) | 13.65% |
| Owned by Institutions (%) | 0.80% |
| Float | 6.02M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.24 |
| Forward PS | n/a |
| PB Ratio | 2.60 |
| P/TBV Ratio | 2.60 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.95 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.31, with a Debt / Equity ratio of 1.20.
| Current Ratio | 1.31 |
| Quick Ratio | 1.21 |
| Debt / Equity | 1.20 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -10.50 |
Financial Efficiency
Return on equity (ROE) is -163.64% and return on invested capital (ROIC) is -99.61%.
| Return on Equity (ROE) | -163.64% |
| Return on Assets (ROA) | -7.65% |
| Return on Invested Capital (ROIC) | -99.61% |
| Return on Capital Employed (ROCE) | -25.13% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $108,749 |
| Profits Per Employee | -$101,860 |
| Employee Count | 82 |
| Asset Turnover | 0.65 |
| Inventory Turnover | 31.90 |
Taxes
| Income Tax | -327,791 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -87.05% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -87.05% |
| 50-Day Moving Average | 0.65 |
| 200-Day Moving Average | 1.40 |
| Relative Strength Index (RSI) | 46.64 |
| Average Volume (20 Days) | 33,826 |
Short Selling Information
The latest short interest is 113,981, so 0.61% of the outstanding shares have been sold short.
| Short Interest | 113,981 |
| Short Previous Month | 111,238 |
| Short % of Shares Out | 0.61% |
| Short % of Float | 1.89% |
| Short Ratio (days to cover) | 4.08 |
Income Statement
In the last 12 months, BMGL had revenue of $8.92 million and -$8.35 million in losses. Loss per share was -$0.44.
| Revenue | 8.92M |
| Gross Profit | 1.89M |
| Operating Income | -1.68M |
| Pretax Income | -8.68M |
| Net Income | -8.35M |
| EBITDA | -1.60M |
| EBIT | -1.68M |
| Loss Per Share | -$0.44 |
Full Income StatementBalance Sheet
The company has $7.71 million in cash and $5.13 million in debt, with a net cash position of $2.58 million or $0.14 per share.
| Cash & Cash Equivalents | 7.71M |
| Total Debt | 5.13M |
| Net Cash | 2.58M |
| Net Cash Per Share | $0.14 |
| Equity (Book Value) | 4.27M |
| Book Value Per Share | 0.23 |
| Working Capital | 2.46M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$3.18 million and capital expenditures -$8.56 million, giving a free cash flow of -$11.63 million.
| Operating Cash Flow | -3.18M |
| Capital Expenditures | -8.56M |
| Depreciation & Amortization | 83,815 |
| Net Borrowing | 3.89M |
| Free Cash Flow | -11.63M |
| FCF Per Share | -$0.62 |
Full Cash Flow StatementMargins
Gross margin is 21.18%, with operating and profit margins of -18.85% and -93.67%.
| Gross Margin | 21.18% |
| Operating Margin | -18.85% |
| Pretax Margin | -97.35% |
| Profit Margin | -93.67% |
| EBITDA Margin | -17.91% |
| EBIT Margin | -18.85% |
| FCF Margin | n/a |
Dividends & Yields
BMGL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.61% |
| Shareholder Yield | -15.61% |
| Earnings Yield | -75.35% |
| FCF Yield | -104.93% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BMGL has an Altman Z-Score of 4.4 and a Piotroski F-Score of 2.
| Altman Z-Score | 4.4 |
| Piotroski F-Score | 2 |
